253 related articles for article (PubMed ID: 21787175)
21. Stereoselective inhibition of human platelet aggregation by R-138727, the active metabolite of CS-747 (prasugrel, LY640315), a novel P2Y12 receptor inhibitor.
Hasegawa M; Sugidachi A; Ogawa T; Isobe T; Jakubowski JA; Asai F
Thromb Haemost; 2005 Sep; 94(3):593-8. PubMed ID: 16268477
[TBL] [Abstract][Full Text] [Related]
22. Choices for Potent Platelet Inhibition in Patients With Diabetes Mellitus.
Storey RF; Parker WA
Circulation; 2016 Sep; 134(11):793-6. PubMed ID: 27619715
[No Abstract] [Full Text] [Related]
23. Comparison of speed of onset of platelet inhibition after loading doses of clopidogrel versus prasugrel in healthy volunteers and correlation with responder status.
Weerakkody GJ; Jakubowski JA; Brandt JT; Farid NA; Payne CD; Zhu J; Warner MR; Naganuma H; Winters KJ
Am J Cardiol; 2007 Jul; 100(2):331-6. PubMed ID: 17631093
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of platelet aggregation with prasugrel and clopidogrel: an integrated analysis in 846 subjects.
Li YG; Ni L; Brandt JT; Small DS; Payne CD; Ernest CS; Rohatagi S; Farid NA; Jakubowski JA; Winters KJ
Platelets; 2009 Aug; 20(5):316-27. PubMed ID: 19637095
[TBL] [Abstract][Full Text] [Related]
25. Increased active metabolite formation explains the greater platelet inhibition with prasugrel compared to high-dose clopidogrel.
Payne CD; Li YG; Small DS; Ernest CS; Farid NA; Jakubowski JA; Brandt JT; Salazar DE; Winters KJ
J Cardiovasc Pharmacol; 2007 Nov; 50(5):555-62. PubMed ID: 18030066
[TBL] [Abstract][Full Text] [Related]
26. Ticagrelor, but not clopidogrel and prasugrel, prevents ADP-induced vascular smooth muscle cell contraction: a placebo-controlled study in rats.
Grzesk G; Kozinski M; Navarese EP; Krzyzanowski M; Grzesk E; Kubica A; Siller-Matula JM; Castriota F; Kubica J
Thromb Res; 2012 Jul; 130(1):65-9. PubMed ID: 22265722
[TBL] [Abstract][Full Text] [Related]
27. Prasugrel inhibits platelet-leukocyte interaction and reduces inflammatory markers in a model of endotoxic shock in the mouse.
Totani L; Dell'Elba G; Martelli N; Di Santo A; Piccoli A; Amore C; Evangelista V
Thromb Haemost; 2012 Jun; 107(6):1130-40. PubMed ID: 22436970
[TBL] [Abstract][Full Text] [Related]
28. Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjects.
Jakubowski JA; Payne CD; Weerakkody GJ; Brandt JT; Farid NA; Li YG; Naganuma H; Lachno DR; Winters KJ
J Cardiovasc Pharmacol; 2007 Mar; 49(3):167-73. PubMed ID: 17414229
[TBL] [Abstract][Full Text] [Related]
29. Clopidogrel versus prasugrel in rabbits. Effects on thrombosis, haemostasis, platelet function and response variability.
Wong PC; Crain EJ; Watson CA; Hua J; Schumacher WA; Rehfuss R
Thromb Haemost; 2009 Jan; 101(1):108-15. PubMed ID: 19132196
[TBL] [Abstract][Full Text] [Related]
30. Residual platelet activation through protease-activated receptors (PAR)-1 and -4 in patients on P2Y12 inhibitors.
Badr Eslam R; Lang IM; Koppensteiner R; Calatzis A; Panzer S; Gremmel T
Int J Cardiol; 2013 Sep; 168(1):403-6. PubMed ID: 23041015
[TBL] [Abstract][Full Text] [Related]
31. Selective blockade of P2Y12 receptors by prasugrel inhibits myocardial infarction induced by thrombotic coronary artery occlusion in rats.
Sugidachi A; Yamaguchi S; Jakubowski JA; Ohno K; Tomizawa A; Hashimoto M; Niitsu Y
J Cardiovasc Pharmacol; 2011 Sep; 58(3):329-34. PubMed ID: 21697729
[TBL] [Abstract][Full Text] [Related]
32. Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile.
Jakubowski JA; Winters KJ; Naganuma H; Wallentin L
Cardiovasc Drug Rev; 2007; 25(4):357-74. PubMed ID: 18078435
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and pharmacodynamics following maintenance doses of prasugrel and clopidogrel in Chinese carriers of CYP2C19 variants.
Kelly RP; Close SL; Farid NA; Winters KJ; Shen L; Natanegara F; Jakubowski JA; Ho M; Walker JR; Small DS
Br J Clin Pharmacol; 2012 Jan; 73(1):93-105. PubMed ID: 21689142
[TBL] [Abstract][Full Text] [Related]
34. Modification of the VerifyNow® P2Y12 test BASE channel to accommodate high levels of P2Y(12) antagonism.
Jakubowski JA; Zhou C; Egan B; Wells M; Kotob-Yahfoufi M; Sugidachi A; Dahlen JR
Platelets; 2011; 22(8):619-25. PubMed ID: 21639823
[TBL] [Abstract][Full Text] [Related]
35. Subacute stent thrombosis owing to complete clopidogrel resistance successfully managed with prasugrel.
Flaherty MP; Johnston PV; Rade JJ
J Invasive Cardiol; 2011 Jul; 23(7):300-4. PubMed ID: 21725128
[TBL] [Abstract][Full Text] [Related]
36. A comparison of the antiplatelet effects of prasugrel and high-dose clopidogrel as assessed by VASP-phosphorylation and light transmission aggregometry.
Jakubowski JA; Payne CD; Li YG; Farid NA; Brandt JT; Small DS; Salazar DE; Winters KJ
Thromb Haemost; 2008 Jan; 99(1):215-22. PubMed ID: 18217157
[TBL] [Abstract][Full Text] [Related]
37. Greater inhibition of platelet aggregation and reduced response variability with prasugrel versus clopidogrel: an integrated analysis.
Weerakkody GJ; Jakubowski JA; Brandt JT; Payne CD; Naganuma H; Winters KJ
J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):205-12. PubMed ID: 17875947
[TBL] [Abstract][Full Text] [Related]
38. The platelet P2Y₁₂ receptor for adenosine diphosphate: congenital and drug-induced defects.
Cattaneo M
Blood; 2011 Feb; 117(7):2102-12. PubMed ID: 20966167
[TBL] [Abstract][Full Text] [Related]
39. Prasugrel for the treatment of coronary thrombosis: a review of pharmacological properties, indications for use and future development.
Tomasello SD; Tello-Montoliu A; Angiolillo DJ
Expert Opin Investig Drugs; 2011 Jan; 20(1):119-33. PubMed ID: 21143003
[TBL] [Abstract][Full Text] [Related]
40. Effects of prasugrel on platelet inhibition during systemic endotoxaemia: a randomized controlled trial.
Spiel AO; Derhaschnig U; Schwameis M; Bartko J; Siller-Matula JM; Jilma B
Clin Sci (Lond); 2012 Nov; 123(10):591-600. PubMed ID: 22646240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
